Table 1 Characteristics of the patients at baseline
Characteristics of the Patients at Baseline | Total population (n = 257) | SR-group (n = 148) | AF-group (n = 109) | p Value |
|---|---|---|---|---|
Age — yr | 80.8 ± 6.0 | 80.6 ± 6.0 | 80.9 ± 6.0 | 0.736 |
Male sex — no. (%) | 118 (45.9%) | 62 (41.9%) | 56 (51.4%) | 0.163 |
Body-mass index (kg/m2) | 28.2 ± 5.5 | 28.3 ± 5.6 | 28.1 ± 5.3 | 0.724 |
Diabetes mellitus (n. %) | 110 (42.8%) | 57 (38.5%) | 53 (48.6%) | 0.126 |
Diabetes treated with insulin | 68 (26.5%) | 33 (22.3%) | 35 (32.1%) | 0.087 |
Hypertension | 223 (86.8%) | 126 (85.1%) | 97 (89.0%) | 0.457 |
Dyslipidemia (n. %) | 179 (69.6%) | 102 (68.9%) | 77 (70.6%) | 0.785 |
PAD | 40 (15.6%) | 17 (11.5%) | 23 (21.1%) | 0.038 |
Chronic obstructive pulmonary disease (n %) | 50 (19.5%) | 33 (22.3%) | 17 (15.6%) | 0.204 |
Medical history — no. (%) | ||||
Chronic kidney disease on dialysis | 8 (3.1%) | 7 (4.7%) | 1 (0.9%) | 0.143 |
History of cancer | 64 (24.9%) | 40 (27.0%) | 24 (22.0%) | 0.384 |
Active cancer | 20 (7.8%) | 10 (6.8%) | 10 (9.2%) | 0.489 |
Coronary heart disease | 210 (81.7%) | 120 (81.1%) | 90 (82.6%) | 0.871 |
Coronary-artery bypass surgery | 36 (14.0%) | 18 (12.2%) | 18 (16.5%) | 0.365 |
Myocardial infarction | 30 (11.7%) | 15 (10.1%) | 15 (13.8%) | 0.433 |
PCI | 67 (26.1%) | 42 (28.4%) | 25 (22.9%) | 0.389 |
Pacemaker | 32 (12.5%) | 11 (7.4%) | 21 (19.3%) | 0.007 |
Stroke | 40 (15.6%) | 22 (14.9%) | 18 (16.5%) | 0.731 |
NYHA III | 164 (63.8%) | 96 (64.9%) | 68 (62.4%) | 0.695 |
NYHA IV | 61 (23.7%) | 31 (20.9%) | 30 (27.5%) | 0.238 |